Delivery Order SPE2DB24D1205-SPE2DB25FCWHQ
Award Date
5/1/25
Potential Completion Date
5/22/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,604.40, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen, a for-profit organization, is the prime contractor for this award, which is not...
This is a $13,953.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award is not associated with a set-aside program and has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,651.10, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business type. In addition to this delivery order,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,953.30, is for the supply of 4567037179 - LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,255.50, is a delivery order for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML". The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,592.23, is for the delivery of LEQVIO 284 MG/1.5 ML syringes to support military healthcare programs. It is a firm fixed-price delivery order contract with a completion date of December 10, 2024. The contract is not set aside for any specific business category. AmerisourceBergen holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,953.30, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 27, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract is a Delivery Order with a Firm Fixed Price of $2,197.41 and an Ultimate Completion Date of June 28, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for providing logistics, acquisition, and technical services to the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $9,302.20, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 28, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen...
This federal contract award is for the delivery of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The $9,093.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...